ORNBV Orion Oyj Class B

Change in Orion Group Executive Management Board as of February 1st, 2024 – Julia Macharey appointed Senior Vice President, People & Culture

Change in Orion Group Executive Management Board as of February 1st, 2024 – Julia Macharey appointed Senior Vice President, People & Culture

ORION CORPORATION

STOCK EXCHANGE RELEASE – CHANGES BOARD/MANAGEMENT/AUDITORS

22 August 2023 at 14.00 EEST             

        

Change in Orion Group Executive Management Board as of February 1st, 2024Julia Macharey appointed Senior Vice President, People & Culture

Ms. Julia Macharey has been appointed Senior Vice President of Orion Group’s new People & Culture group-level function and member of the Executive Management Board of Orion Group as of February 1st 2024. She will report to President & CEO Liisa Hurme. She currently holds the position of Senior Vice President, Human Resources and Operational Development at Valmet and is a member of the Valmet Executive Team. Julia Macharey holds a Master of Science degree in Economics and a Bachelor of Arts degree.

“With this appointment, I wanted to support the implementation of our global growth strategy and to strengthen the building of Orion's corporate culture. Based on her previous experience and track record, Julia Macharey will bring both global organizational and business perspective to Orion," says Orion’s President & CEO Liisa Hurme.

“I am very excited about the opportunity of joining a team of world-class experts who endeavor to improve well-being through life-saving and life-improving medicines and treatments. Orion’s people-oriented culture based on working together to create high-quality products is only one of the many reasons why I am looking forward to supporting Orion on its growth path,” says Julia Macharey about the appointment.

The new People & Culture function will focus on developing Orion’s professionals, capabilities and company culture and supporting growth, and Human Resources will be at the heart of this new group-level function as of February 1st.

“Orion’s organisation has seen significant geographical expansion in recent years, and we want to continue developing our people and culture in a global and systematic way. I am excited about the new opportunities in this and I warmly welcome Julia to Orion and to our management team,” says Liisa Hurme.

ANNEX: CV of Julia Macharey



Julia Macharey

Born 1977

Finnish citizen



Education:

Master of Science in Economics, University of Jyväskylä, 2000

Bachelor of Arts (Intercultural Communication), University of Jyväskylä, 1999



Career:

Valmet

2019–              Senior Vice President, Human Resources and Operational Development

2014–2019        Senior Vice President, Human Resources



Metso Corporation, Metso Paper

2012–2013        Senior Vice President, Human Resources of Metso Pulp, Paper and Power segment



Pöyry Plc        

2007–2012        Vice President, Human Resources of Industry Business Group





Nokia Corporation

2006–2007        Senior Manager, Business HR of Manufacturing Solutions

2004–2006        Senior Manager, Business HR of Sourcing and Procurement

SCA Hygiene Products Ltd and GmbH

2000–2004        Human Resources Manager and various HR management responsibilities

Attachment:

  •  (image)

Orion Corporation

Liisa Hurme



President and CEO
    Olli Huotari



SVP, Corporate Functions
 

                                                

Contact person:

Liisa Hurme, President and CEO

tel. +358 50 966 2874,

Contact person for the media:

Terhi Ormio, VP, Communications

tel. + 358 50 966 4646,

Publisher:

Orion Corporation

Communications

Orionintie 1A, FI-02200 Espoo, Finland



Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and self-care products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2022 amounted to EUR 1,341 million and the company had about 3,500 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.

 

Attachment



EN
22/08/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Orion Oyj Class B

Orion Oyj: 1 director

A director at Orion Oyj sold 4,000 shares at 64.481EUR and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...

 PRESS RELEASE

Orion Corporation: Managers’ transactions – Juhani Kankaanpää

Orion Corporation: Managers’ transactions – Juhani Kankaanpää ORION CORPORATION MANAGERS’ TRANSACTIONS 8 AUGUST 2025 at 9.30 EEST         Orion Corporation: Managers’ transactions – Juhani Kankaanpää Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. Orion Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Juhani KankaanpääPosition...

 PRESS RELEASE

Orion Oyj: Johtohenkilöiden liiketoimet – Juhani Kankaanpää

Orion Oyj: Johtohenkilöiden liiketoimet – Juhani Kankaanpää ORION OYJ        JOHTOHENKILÖIDEN LIIKETOIMET         8.8.2025 KLO 9.30          Orion Oyj: Johtohenkilöiden liiketoimet – Juhani Kankaanpää Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen johtohenkilön tai johtohenkilön lähipiirin liiketoimista Orionin osakkeilla tai muilla Orioniin liittyvillä rahoitusvälineillä. Orion Oyj - Johdon liiketoimet____________________________________________IlmoitusvelvollinenNimi: Juhani KankaanpääAsema: Muu ylin johtoLiikkeeseenlaskija: Or...

 PRESS RELEASE

Orion Corporation: Managers’ transactions – Satu Ahomäki

Orion Corporation: Managers’ transactions – Satu Ahomäki ORION CORPORATION MANAGERS’ TRANSACTIONS 4 August 2025 at 16:10 EEST         Orion Corporation: Managers’ transactions – Satu Ahomäki Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. Orion Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Satu AhomäkiPosition: Other senior...

 PRESS RELEASE

Orion Oyj: Johtohenkilöiden liiketoimet – Satu Ahomäki

Orion Oyj: Johtohenkilöiden liiketoimet – Satu Ahomäki ORION OYJ        JOHTOHENKILÖIDEN LIIKETOIMET         4.8.2025 KLO 16.10         Orion Oyj: Johtohenkilöiden liiketoimet – Satu Ahomäki Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen johtohenkilön tai johtohenkilön lähipiirin liiketoimista Orionin osakkeilla tai muilla Orioniin liittyvillä rahoitusvälineillä. Orion Oyj - Johdon liiketoimet____________________________________________IlmoitusvelvollinenNimi: Satu AhomäkiAsema: Muu ylin johtoLiikkeeseenlaskija: Orion OyjLEI: 743...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch